BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry 2021;11:574. [PMID: 34750350 DOI: 10.1038/s41398-021-01706-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Olsen AS, Lykkebo-valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S, Mørup M, Ganz M, Knudsen GM, Fisher PM. Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects. NeuroImage 2022;264:119716. [DOI: 10.1016/j.neuroimage.2022.119716] [Reference Citation Analysis]
2 Kanen JW, Luo Q, Rostami Kandroodi M, Cardinal RN, Robbins TW, Nutt DJ, Carhart-harris RL, den Ouden HEM. Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans. Psychol Med 2022. [DOI: 10.1017/s0033291722002963] [Reference Citation Analysis]
3 Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J. Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers.. [DOI: 10.1101/2022.10.31.22281688] [Reference Citation Analysis]
4 Kwan AC, Olson DE, Preller KH, Roth BL. The neural basis of psychedelic action. Nat Neurosci 2022. [DOI: 10.1038/s41593-022-01177-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wolf G, Singh S, Blakolmer K, Lerer L, Lifschytz T, Heresco-levy U, Lotan A, Lerer B. Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Mol Psychiatry 2022. [DOI: 10.1038/s41380-022-01832-z] [Reference Citation Analysis]
6 Mallaroni P, Mason NL, Kloft L, Reckweg JT, van Oorsouw K, Toennes SW, Tolle HM, Amico E, Ramaekers JG. Ritualistic use of ayahuasca enhances a shared functional connectome identity with others.. [DOI: 10.1101/2022.10.07.511268] [Reference Citation Analysis]
7 Calder AE, Hasler G. Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 2022. [PMID: 36123427 DOI: 10.1038/s41386-022-01389-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2022. [PMID: 36001306 DOI: 10.1001/jamapsychiatry.2022.2096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Doss MK, Barrett FS, Corlett PR. Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds. ACS Chem Neurosci 2022. [PMID: 36001741 DOI: 10.1021/acschemneuro.2c00461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gargiulo AT, Hu J, Ravaglia IC, Hawks A, Li X, Sweasy K, Grafe L. Sex differences in cognitive flexibility are driven by the estrous cycle and stress-dependent. Front Behav Neurosci 2022;16:958301. [DOI: 10.3389/fnbeh.2022.958301] [Reference Citation Analysis]
11 van Elk M, Yaden DB. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. Neurosci Biobehav Rev 2022;140:104793. [PMID: 35878791 DOI: 10.1016/j.neubiorev.2022.104793] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Foldi CJ, James MH, Brown RM, Piya MK, Steward T. Advancing translational neuroscience research for eating disorders. Aust N Z J Psychiatry 2022;56:739-41. [PMID: 35674383 DOI: 10.1177/00048674221106678] [Reference Citation Analysis]
13 Knudsen GM. Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology 2022. [PMID: 35729252 DOI: 10.1038/s41386-022-01361-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Viktorin V, Griškova-bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T. Psilocybin—Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience. JPM 2022;12:1004. [DOI: 10.3390/jpm12061004] [Reference Citation Analysis]
15 Shiroma PR, Velit-Salazar MR, Vorobyov Y. A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population. Clin Drug Investig 2022. [PMID: 35672558 DOI: 10.1007/s40261-022-01169-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Klöbl M, Prillinger K, Diehm R, Doganay K, Lanzenberger R, Poustka L, Plener P, Konicar L. Volitional brain regulation is related to improvements in affective characteristics of adolescents with autism spectrum disorder.. [DOI: 10.1101/2022.05.24.22275449] [Reference Citation Analysis]
17 Tomažič T, Čelofiga AK. The Role of Different Behavioral and Psychosocial Factors in the Context of Pharmaceutical Cognitive Enhancers’ Misuse. Healthcare 2022;10:972. [DOI: 10.3390/healthcare10060972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wießner I, Olivieri R, Falchi M, Palhano-fontes F, Oliveira Maia L, Feilding A, B. araujo D, Ribeiro S, Tófoli LF. LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility. European Neuropsychopharmacology 2022;58:7-19. [DOI: 10.1016/j.euroneuro.2022.01.114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Cole-turner R. Psychedelic Mystical Experience: A New Agenda for Theology. Religions 2022;13:385. [DOI: 10.3390/rel13050385] [Reference Citation Analysis]
20 van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH. How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Psychopharmacology (Berl) 2022. [PMID: 35348806 DOI: 10.1007/s00213-022-06106-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. J Psychopharmacol 2022;36:151-8. [PMID: 35166158 DOI: 10.1177/02698811211073759] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
22 Safron A, Klimaj V, Hipólito I. On the Importance of Being Flexible: Dynamic Brain Networks and Their Potential Functional Significances. Front Syst Neurosci 2022;15:688424. [DOI: 10.3389/fnsys.2021.688424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF. Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. Front Neuroergonomics 2022;2:784576. [DOI: 10.3389/fnrgo.2021.784576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. Front Psychiatry 2021;12:800072. [PMID: 34975593 DOI: 10.3389/fpsyt.2021.800072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
25 Chen D, Lei X, Du L, Long Z. Use of machine learning in predicting the efficacy of repetitive transcranial magnetic stimulation on treating depression based on functional and structural thalamo-prefrontal connectivity: A pilot study. Journal of Psychiatric Research 2022. [DOI: 10.1016/j.jpsychires.2022.01.064] [Reference Citation Analysis]
26 Kuburi S, Di Passa A, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review. Chronic Stress 2022;6:247054702211153. [DOI: 10.1177/24705470221115342] [Reference Citation Analysis]